	Do Obsessive-Compulsive Symptoms Increase the Risk of Developing Psychosis? A Systematic Review and Meta-analysis. Schizophr Bull Open Hinton W, Vivolo M, Jimenez E, Hodgekins J. PMID: 42183483 [PubMed]
	The Global Burden of Schizophrenia: Findings from the 2021 Global Burden of Diseases, Injuries, and Risk Factors Study. Schizophr Bull Open GDB 2021 Schizophrenia Collaborators. PMID: 42183482 [PubMed]
	Genetic Pathways Point to the Biology Underlying the Association Between Cannabis Use Disorder and Psychosis. Biol Psychiatry Glob Open Sci Austin-Zimmerman I, Li Q, Johnson EC, Trotta G, Spinazzola E, Coleman JRI, Li Z, Bond BW, Quattrone D, Levey DF, Gelernter J, Jauhar S, Murray RM, Sham P, Vassos E, Di Forti M. PMID: 42181294 [PubMed]
	Insomnia severity as partial mediator of the relationship between post-traumatic stress symptoms and psychotic experiences: a cross-sectional study among community adolescents following multiple trauma exposure. J Child Adolesc Trauma Fekih-Romdhane F, Malaeb D, Obeid S, Dagher D, Dabbous M, Sakr F, Hallit S. PMID: 42179416 [PubMed]
	Prevalence and clinical correlates of suicidal ideation and aggression in patients with chronic schizophrenia: large-scale, cross-sectional study. BJPsych Open Fan R, Zhu R, Guo Q, Rao G, Wang D, Zhang XY. PMID: 42179178 [PubMed]
	The safety and efficacy of semaglutide in people with schizophrenia spectrum disorders: systematic review and meta-analysis of randomised controlled trials. BJPsych Open Trott M, Arnautovska U, Johnston D, Ritchie G, Siskind D. PMID: 42179170 [PubMed]
	The role of self-criticism and self-compassion in psychotic experiences and associated distress - Risk or resilience? A systematic literature review. Psychol Psychother Crawford M, Terry R, Jameel L. PMID: 42178875 [PubMed - as supplied by publisher]
	Executive function profiles identify stable schizophrenia subtypes with distinct symptoms, biological markers and treatment responses: a cross-time clustering and validation study. BMC Med Zhang T, Huo X, Chen J, Zhao X. PMID: 42178548 [PubMed - as supplied by publisher]
	Dissociation between the dynamics of symptom scores and network metrics in psychosis treatment: a proof-of-concept study using network intervention analysis. Psychopharmacology (Berl) Sarti P, Cecere G, Omlor W, Edkins V, Blom JMC, Homan P. PMID: 42178405 [PubMed - as supplied by publisher]
	Effect of continuation treatment on health-related quality of life in remitted psychotic depression. J Affect Disord Bendel RA, Alexopoulos GS, Marino P, Meyers BS, Mulsant BH, Neufeld NH, Rothschild AJ, Voineskos AN, Whyte EM, Flint AJ, Bingham KS, STOP-PD II Study Group. PMID: 42176815 [PubMed - as supplied by publisher]
	A network analysis of psychotic symptoms, neurocognition, alexithymia, empathy, and suicidal intent in patients with chronic schizophrenia. Schizophr Res Wu M, Li Z, Wang Y, Zhang X, Yan K, Xu H, Wang X, Liu T, Wu Q, Zhang X. PMID: 42176686 [PubMed - as supplied by publisher]
	Automated Symptom Identification from Clinical Interview Transcripts in Diagnosed Schizophrenia: A Multi-Agent LLM Framework. Stud Health Technol Inform Zhang P, Mao J. PMID: 42174998 [PubMed - indexed for MEDLINE]
	Changes in insight and outcome over the early course of first-episode psychosis. The OPTiMiSE trial. Schizophr Res Cogn Lopez-Morinigo JD, Diaz-Caneja CM, Galvañ J, Fraguas D, Moreno C, Berger G, Leucht S, Rossum IW, David AS, Arango C. PMID: 42169702 [PubMed]
	White matter microstructure in relatives of people with schizophrenia or bipolar disorder: an ENIGMA meta-analysis. Mol Psychiatry Barendse MEA, Poortman SR, Ching CRK, Cahn W, Cannon DM, Castro-Fornieles J, Delavari F, Fullerton JM, Hillegers M, McDonald C, Mitchell PB, Mueller BA, Pena M, Ozerdem A, Piguet C, Roberts G, Saccaro LF, Saricicek Aydogan A, de la Serna E, Sponheim SR, Sugranyes G, Xuan L, Zorlu N, Thompson PM, van Haren NEM. PMID: 42168580 [PubMed - as supplied by publisher]
	Inhibitory control deficits and ventral attention network alterations linked to apathy in schizophrenia. Transl Psychiatry Deng W, van Tol MJ, Marsman JC, Kos C, Servaas MN, Aleman A. PMID: 42168148 [PubMed - as supplied by publisher]
	Early-Onset Cannabis Use, Retinal Biomarkers, and Risk for Schizophrenia Preliminary Study. Clin Ther Valenti DA, Kailher H. PMID: 42167975 [PubMed - as supplied by publisher]
	Impact of pre-existing schizophrenia spectrum disorder on the receipt of surgery and other treatments for non-small cell lung cancer: A multicenter nationwide cohort study in Japan. Chest Yamada Y, Fujiwara M, Ishii T, Watanabe T, Fujimori M, Nakaya N, Kawamura T, Otsuki K, Ichihara E, Shimazu T, Hinotsu S, Uchitomi Y, Inagaki M. PMID: 42167588 [PubMed - as supplied by publisher]
	Estradiol surges as dual-purpose mechanisms in evolutionary psychiatry: Neuroendocrine stabilization, stress regulation, and psychosis vulnerability. Neurosci Biobehav Rev Carlson J, Kulkarni J. PMID: 42167420 [PubMed - as supplied by publisher]
	Basic Sensory Risk Markers Characteristic of Schizophrenia in Autism Spectrum Disorder: A Systematic Review and Meta-Analysis. Neurosci Biobehav Rev Ragalmuto FGM, Oranje B, Ziermans T. PMID: 42167419 [PubMed - as supplied by publisher]
	Medication adherence, cannabis use, and depressive symptoms in first-episode psychosis: longitudinal study. J Ment Health Ricci V, Sarni A, Fraccalini T, Maina G. PMID: 42166351 [PubMed - as supplied by publisher]

Articles 1 - 20 / 68882

Page 1 of 3445



		Time frame

	Mediscope AG E-mail: info@mediscope.ch
	Disclaimer \| Privacy Policy